Literature DB >> 15265818

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin.

Ursula Meier1, Axel M Gressner.   

Abstract

BACKGROUND: Recent studies point to the adipose tissue as a highly active endocrine organ secreting a range of hormones. Leptin, ghrelin, adiponectin, and resistin are considered to take part in the regulation of energy metabolism. APPROACH: This review summarizes recent knowledge on leptin and its receptor and on ghrelin, adiponectin, and resistin, and emphasizes their roles in pathobiochemistry and clinical chemistry. CONTENT: Leptin, adiponectin, and resistin are produced by the adipose tissue. The protein leptin, a satiety hormone, regulates appetite and energy balance of the body. Adiponectin could suppress the development of atherosclerosis and liver fibrosis and might play a role as an antiinflammatory hormone. Increased resistin concentrations might cause insulin resistance and thus could link obesity with type II diabetes. Ghrelin is produced in the stomach. In addition to its role in long-term regulation of energy metabolism, it is involved in the short-term regulation of feeding. These hormones have important roles in energy homeostasis, glucose and lipid metabolism, reproduction, cardiovascular function, and immunity. They directly influence other organ systems, including the brain, liver, and skeletal muscle, and are significantly regulated by nutritional status. This newly discovered secretory function has extended the biological relevance of adipose tissue, which is no longer considered as only an energy storage site.
SUMMARY: The functional roles, structures, synthesis, analytical aspects, and clinical significance of leptin, ghrelin, adiponectin, and resistin are summarized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265818     DOI: 10.1373/clinchem.2004.032482

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  211 in total

1.  Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects.

Authors:  Patricia A Rouen; Jane L Lukacs; Nancy E Reame
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

Review 2.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

3.  CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.

Authors:  Eran Gershon; Wylie W Vale
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

4.  Relation of the rs6923761 gene variant in glucagon-like peptide 1 receptor with weight, cardiovascular risk factor, and serum adipokine levels in obese female subjects.

Authors:  Daniel Antonio de Luis; Rocío Aller; B de la Fuente; D Primo; Rosa Conde; Olatz Izaola; Manuel Gonzalez Sagrado
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 5.  Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?

Authors:  Jörg Dötsch; Kai Nüsken; Michael Schroth; Wolfgang Rascher; Udo Meissner
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

6.  Potential role of leptin expression in hepatocellular carcinoma.

Authors:  S-N Wang; Y-T Yeh; S-F Yang; C-Y Chai; K-T Lee
Journal:  J Clin Pathol       Date:  2006-03-24       Impact factor: 3.411

7.  Cord blood leptin and adiponectin as predictors of adiposity in children at 3 years of age: a prospective cohort study.

Authors:  Christos S Mantzoros; Sheryl L Rifas-Shiman; Catherine J Williams; Jessica L Fargnoli; Theodoros Kelesidis; Matthew W Gillman
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

8.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

Review 9.  Obesity and Migraine in Childhood.

Authors:  Tal Eidlitz Markus; Irene Toldo
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

10.  Predicting maximum Roux-en-Y gastric bypass-induced weight reduction--preoperative plasma leptin or body weight?

Authors:  Leszek Czupryniak; Maciej Pawlowski; Anna Kumor; Dariusz Szymanski; Jerzy Loba; Janusz Strzelczyk
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.